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Abstract 
 
The chief objective of the current study was to investigate the auditory status in a group of adults with AIDS before 
commencing antiretroviral therapy (ART) in a hospital outpatient clinic in Gauteng, South Africa. A total sample of 150 
participants, aged between 20 and 46 years, was assessed following a prospective qualitative research design. All participants 
underwent case history interviews and medical record reviews, otoscopy and tympanometry, as well as conventional pure 
tone audiometry testing. Descriptive statistics was used to analyse data obtained. Prevalence, type, degree, configuration, and 
symmetry of the auditory manifestations; as well as type of onset of hearing loss and the possible causes of the auditory 
manifestations were analysed. Findings indicated that auditory manifestations in adults with AIDS are varied in nature and 
are possibly due to a number of causes. Manifestations including hearing loss, tinnitus and vertigo (in varied combinations) 
were found; with the types of hearing loss being mainly sensorineural in nature. The severity of hearing loss ranged from 
mild to severe, occurred either unilaterally or bilaterally; with the type of onset being mainly gradual and progressive in 
nature. The varied causes of hearing loss included HIV infection or AIDS illness as a primary cause, opportunistic infections, 
and various ototoxic therapies that the patients had undergone. Implications for future research as well as future assessment 
and management of patients with AIDS are raised. 
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Introduction 
 
The HIV pandemic in South Africa, now in its third decade, remains one of the biggest challenges this country has 
to confront. This occurs together with poverty, joblessness and other socio-economic challenges that the departments of 
health and social development strive to eradicate (Posel, Kahn and Walker, 2007). The HIV pandemic appears to have 
debatably generated more challenges to science and medicine than any other single disease. The virus has taken a huge toll in 
human suffering and has had an astounding socio-economic impact on healthcare in South Africa, and throughout the world, 
with conceivably more significant challenges occurring in third-world countries than in developed countries (Goudge, Gilson, 
Russel, Gumede and Mills, 2009). It is also believed that the incidence of HIV has also crafted a devastating burden and 
inimitable challenge to audiological health-service delivery in South Africa (Swanepoel, 2006; Khoza-Shangase, Mupawose, 
and Mlangeni. 2009). This challenge can partially be surmounted by ensuring that relevant amount of research is conducted 
to establish the physiological effects of HIV/ AIDS and its drug treatments on those who are infected.  
Globally, research has shown numerous associations between HIV/AIDS and auditory performance in adults, 
including sensorineural hearing loss possibly linked with antiretroviral therapy (ART). However, the acquired evidence is 
predominantly from the developed world and research from developing countries remains limited. The known effects of HIV/ 
AIDS on the auditory system are based mainly on cross-sectional studies and case reports conducted internationally in 
industrialised countries, with very scant information emanating from third-world countries where the presentation of the virus 
and its treatments may be different. Although much research has been conducted internationally, replication of such studies 
in the developing world is still required. The current study investigates specifically the auditory manifestations of AIDS in 
adults. 
There are suggestions that hearing changes may be one of the presentations at any stage of HIV disease (Birchall, 
Wight, French, Cockbain and Smith, 1992; Noffsinger and Friedman, 1996; Campanini, Marani, Mastroianni, Cancellieri and 
Vicini, 2005; Khoza-Shangase, 2010). The documented prevalence and incidence of hearing loss in cases of HIV/ AIDS 
varies extensively, but this discrepancy may be credited to the vastly diverse samples, variable research methodologies, as 
well as different participant inclusion criteria used in the published studies. In general, the incidence of otologic 
manifestations of HIV/AIDS has been described to be reasonably small (Abemayor and Calcaterra, 1983; Kohan, Rothstein 
and Cohen, 1988; Lalwani and Sooy, 1992; Gold and Tami, 1998; Chandrasekhar, Connelly, Brahmbhatt, Chetan, Shah, 
Kloser and Baredes, 2000; Khoza and Ross, 2002). However, Flower (1991) reported on the high prevalence of hearing loss 
in patients with HIV/ AIDS when he declared that about 75% of adults with AIDS illness and 50% of persons with AIDS-
related complex will present with clinical auditory-system abnormalities. Other researchers, such as Sooy (1987), have 
indicated that hearing impairment occurs in up to half of patients with AIDS. Khoza and Ross (2002) reported findings from 
South Africa, where hearing loss was found in 23% of their study sample of persons with HIV/ AIDS. The different results 
reported by these studies could well be due to methodological differences as opposed to differences in actual incidence of 
hearing loss (Khoza-Shangase, 2010). The most obvious difference among these studies is that while some focused on 
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general HIV/ AIDS (with samples that included patients in all stages of HIV disease); others were more specific in their 
sampling. 
Consistent with the reports that state minor auditory manifestations of HIV/ AIDS, are claims that this small 
incidence rate is exclusive to adults, but may be vastly different in children. These studies have resolved that there is an 
extremely low incidence (or no incidence) of otologic disease in adults with HIV infection, with possibly much higher 
incidence in paediatric patients (Khoza-Shangase, 2010). The high occurrence of conductive hearing loss in paediatric 
patients, globally, has been ascribed in part to the high incidence of serous otitis media, which may occur in up to 80% of 
cases (Smith and Canalis, 1989). Rosenberg, Schneider and Cohen (1985) examined medical records of adults with AIDS and 
discovered that while 71% of the patients had symptoms localised in the head and neck, none had otologic signs and 
symptoms. Similar findings were reported by Marcusen and Sooy (1985) who found no otologic abnormalities in their 
sample. Lalwani and Sooy (1992) maintain that otologic manifestations associated with HIV/ AIDS do occur but are less 
prevalent than other head and neck conditions.  
With regard to comparing the occurrence of auditory manifestations to other head and neck effects of HIV/AIDS, 
there is significant variation in the reports. For instance, Rosenberg et al. (1985) reported a total lack of otologic symptoms in 
patients who presented with head and neck signs and symptoms, while Booth (1997) mentioned an upsurge in the number of 
people living with HIV/ AIDS who presented with otologic symptoms. Lalwani and Sooy (1992) maintained that ear-related 
manifestations of HIV/ AIDS occur to a lesser degree when compared to other head and neck conditions. It should be noted 
that none of these studies utilized an audiological test battery method which would facilitate definitive conclusions about the 
auditory symptoms. Chandrasekhar et al. (2000) claimed that as many as one-third of patients with HIV may have significant 
otologic complaints or difficulties, and they maintained that this is a significant percentage that may be higher than figures 
reported in the literature on otolaryngologic and infectious diseases. Research that has incorporated audiological assessments, 
such as Sooy’s (1987) research, illustrate abnormal audiologic findings greater than 25 dB HL on pure-tone testing in 49% of 
the total sample tested, while Birchall et al. (1992) stated a regular presence of hearing loss on pure-tone testing in 39% of a 
small sample of patients. Not so long ago, Prasad, Bhojwani, Shenoy and Prasad (2006) reported that in their study, although 
80% of HIV infections presented with otolaryngologic symptoms, otologic manifestations were seen in only 20% of the cases 
seen, with 13% of these symptoms linked to chronic suppurative otitis media.  
A review of the literature on auditory findings implies variability as far as nature, degree, and configuration of the 
hearing losses diagnosed in patients with HIV/ AIDS. The documented hearing impairment may be conductive, 
sensorineural, or central; the severity of the loss may range from mild to severe; the onset of the loss may be sudden or 
gradual; and the hearing loss may be stable or may fluctuate (Timon and Walsh, 1989; Lalwani and Sooy, 1992; Bankaitis; 
1996; Friedman and Noffsinger, 1998; Chandrasekhar et al., 2000; Khoza and Ross, 2002; Khoza-Shangase, 2010). Khoza 
and Ross (2002) also argue that the hearing loss may also be profound in nature.  
Friedman and Noffsinger (1998), Gold and Tami (1998) and Lalwani and Sooy (1992) have all stated that the most 
common otologic problems reported in this population are serous otitis media and recurrent acute otitis media, which are 
primarily due to eustachian tube dysfunction; suggesting that one would anticipate the conductive type of hearing loss to be 
more common (Khoza-Shangase, 2010). Nevertheless, that finding is not substantiated in the literature. The rate of 
occurrence of sensorineural hearing loss (SNHL) is reported by Gold and Tami (1998) to range between 20% and 50%, based 
on reviews of studies by Bankaitis and Keith (1995), Lalwani and Sooy (1992) and Tami and Lee (1994). Similarly, Khoza 
and Ross (2002) found higher prevalence of SNHL in a sample of adults with HIV infection, where a definite increase in the 
number of occurrences of SNHL from stage 1 (asymptomatic HIV infection) to stage 3 (clinical AIDS) was also established 
in adults who were not on ART.  
Very limited published literature exists with regards the degree of hearing loss in patients with HIV/AIDS. Sooy 
(1987) reported abnormal audiologic results of thresholds worse than 25 dB HL, with a sloping configuration on pure-tone 
audiometry of between 30 and 50 dB HL at 8000 Hz. A third of the patients in Sooy’s study had moderate to severe hearing 
loss at three or more test frequencies, in at least one ear. Chandrasekhar et al. (2000), however indicated that all audiometric 
data in their study (i.e. pure tone, speech discrimination, and otoacoustic emissions), which was collapsed across CDC group, 
otologic complaint and age, there was no statistically significant effect on the ear. However, when data for right and left ear 
were combined, a statistically significant effect for the high frequencies (4000–8000 Hz) was found; with these high 
frequencies being significantly elevated relative to lower frequencies. Likewise, previously reported results have revealed 
that the audiometric data trends suggest deteriorating hearing loss in high frequencies. For example, Marcusen and Sooy 
(1985) found that some of their patients presented with a hearing loss on pure-tone testing involving 8000 Hz.  
Chandrasekhar et al. (2000), Gold and Tami (1998) and Lalwani and Sooy (1992) state that such hearing loss 
steadily worsens with an increase in frequency, with high frequencies at a moderate degree of severity. Mata, Yebra Bango, 
Tutor de Ureta, Villarreal and Garcia (2000) reported that high-frequency sensorineural hearing loss was a common finding 
among the 30 patients studied. However, Khoza and Ross (2002) claim that the configuration of the hearing loss in HIV 
disease may not be frequency-range-specific, but may involve all frequencies. Again, these variations in reports may be 
attributed to the differences in the samples studied.  
The description of hearing impairment in HIV/ AIDS varies even when one considers type of onset and symmetry 
of hearing loss (Khoza-Shangase, 2010). Several studies have reported on sudden SNHL in patients with HIV or AIDS (Real, 
Thomas and Gerwins, 1987; Timon and Walsh, 1989; Solanellas, Soldado and Lozano, 1996; Khoza and Ross, 2002). Smith 
and Canalis (1989) found that the otologic symptoms can include unilateral or bilateral SNHL, which can occasionally be of 
a sudden onset in nature, but that this loss is commonly rapidly progressive in nature. Khoza and Ross (2002) found the 
sudden onset of the hearing loss to be more prevalent in participants with more severe SNHL than in cases of conductive or 
mixed hearing losses. Chandrasekhar et al. (2000) evaluated 50 patients and reported that of the 29% with hearing loss, 3% 
presented with sudden onset and 21% with gradual onset, with the remainder presenting with intermittent onset of the 
symptoms. Comparison of these studies suggests a greater tendency towards bilateral gradual onset of hearing loss rather than 
sudden onset (Khoza-Shangase, 2010). 
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Numerous clinical and medically oriented studies have exhibited the occurrence of hearing loss and other auditory 
manifestations in HIV/AIDS. According to the literature, auditory abnormalities associated with HIV/AIDS and its 
treatments have been reported in persons with varying degrees of HIV infection, among both symptomatic and asymptomatic 
patients, as well as in patients on ART (Khoza-Shangase, 2010). Indications exist which indicate that the HIV-effects on the 
auditory system can be direct as well as indirect (Larsen, 1998); however, this distinction is not always clear and consistent 
(Khoza-Shangase, 2010). Early reports in the literature showed that HIV infection might directly affect the auditory function 
due to the fact that the virus is neurotropic and commonly manifests itself neurologically (McArthur, 1987), which may be 
what Kallail, Downs and Schertz (2008) refer to as HIV/AIDS being the primary cause of auditory system disorders. 
Reportedly, these direct causes possibly give rise to central auditory pathology found in this population (Bankaitis; 1996; 
Lalwani and Sooy, 1992). More commonly, though, reports in the literature have focused on the indirect effects of the virus 
on the ear. It is believed that indirect causes that result in hearing loss arise from opportunistic infections, which require 
suppressive therapy, thereby leading to ototoxicity (Lalwani and Sooy, 1992; Bankaitis; 1996; Bankaitis and Schountz, 
1998), and which Kallail et al. (2008) refer to as iatrogenic sources (Khoza-Shangase, 2010).  
Larsen’s (1998) more generalised delineation of ‘direct’ versus ‘indirect’ effects of HIV/ AIDS can be applied to 
the causes of auditory manifestations. Based on this distinction, it would seem that, generally, the majority of auditory 
manifestations can be attributed to indirect effects in the form of opportunistic infections (e.g. SNHL due to cytomegalovirus, 
otosyphilis, meningitis, encephalitis, otitis media, and tuberculosis of the ear), and neoplasms, with some direct effects 
including central hearing loss due to primary CNS lymphomas (Friedmann and Arnold, 1993), necrosis of the 
vestibulocochlear nerve due to herpes simplex and herpes zoster, and SNHL due to cryptococcal (Kwartler, Linthicum, Jahn 
and Hawke, 1991) and aseptic meningitis, as well as neurosyphilis (Little, Gardner, Acker and Land, 1995) and 
cytomegalovirus (Meynard, El Amrani, Meyohas, Fligny, Gozlan, Rozenbaum, Roullet and Frottier, 1997). Lastly, the side 
effects of HIV/AIDS treatment can also be viewed as indirect effects (Stern, Lin and Lucente, 1990; Lalwani and Sooy, 1992; 
Friedmann and Arnold, 1993; Gold and Tami, 1998; Larsen, 1998; Chandrasekhar et al., 2000; Khoza-Shangase, 2010). 
A review of the literature with regard to causes of hearing loss in cases of HIV/ AIDS confirms the substantial role 
that opportunistic infections play in the development of auditory manifestations. Khoza and Ross (2002) stated that 
opportunistic infections in the form of intracranial events (such as encephalitis and meningitis), and syphilis and herpes 
contributed to the causes of hearing loss. Moreover, auditory manifestations in this population could be due to the fact that 
serous otitis media and associated conductive hearing loss have been found to be more common, presenting as one of the 
opportunistic infections (Gold and Tami, 1998; Khoza-Shangase, 2010).  
Literature states that conductive hearing loss in this population is commonly caused by otitis media, which may be 
due to eustachian tube dysfunction (Gold and Tami, 1998). Various factors have been associated with this eustachian tube 
dysfunction and middle ear effusions including decreased cell-mediated immunity, recurrent viral infections, non-malignant 
lymphoid hyperplasia of the adenoids, nasopharyngeal tumours, sinusitis, and allergic autoimmune reaction to HIV (Stern, 
Lin, and Lucente, 1990; Lalwani and Sooy, 1992; Friedmann and Arnold, 1993; Gold and Tami, 1998; Khoza-Shangase, 
2010). Chandrasekhar et al. (2000) claim that otitis media, which is reportedly exceptionally scarce in adults with ‘normal’ 
health, affects up to 23% of HIV-infected patients. 
A large body of evidence exists in the literature regarding causes of SNHL in HIV/AIDS (Real et al., 1987; Smith 
and Canalis, 1989; Birchall et al., 1992; Friedmann and Arnold, 1993). Larsen (1998) asserts that the precise cause of SNHL 
in people infected with HIV infection is undetermined, a claim corroborated by Lalwani and Sooy (1992) who argue that in 
up to half of HIV-infected people with hearing loss, no cause can be found. Friedmann and Arnold (1993) associate SNHL in 
HIV/ AIDS to involvement of the central nervous system (CNS) and of the sensory-end organs, which may be due to 
neurosyphilis and neoplasms. According to these authors, these conditions may be complicated by opportunistic infections, 
such as cryptococcus and cytomegalovirus, as well as the side effects of some drugs used to treat the opportunistic infections 
(Khoza-Shangase, 2010).  
Because of all the diseases and infections that the population with HIV/ AIDS presents with, it is not startling to 
find patients with hearing loss attributable to ototoxicity, as this population undergoes treatment that often involves 
potentially ototoxic medications (Birchall et al., 1992; Khoza-Shangase, 2010). Bankaitis and Schountz (1998) report that the 
use of experimental ARVs with undetermined side effects contributes to this occurrence of hearing loss. Additionally, 
ototoxic drugs that are often utilized in the management of opportunistic infections (such as tuberculosis) may raise the 
possibility for drug-induced hearing loss in this population.  
The current study which aimed at determining the auditory manifestations of AIDS was therefore conducted in 
order to increase the evidence base that is more contextually relevant.   
 
 
Methodology 
Research Aim and Objectives 
Primary Aim 
 
To investigate the auditory status in a group of adults with AIDS prior to commencement of antiretroviral therapy 
in a hospital outpatient clinic in Gauteng, South Africa. 
 
Specific Objectives 
 
1. To estimate the prevalence of hearing loss and the presence of other otologic effects over and above hearing 
impairment (tinnitus, aural fullness, disequilibrium, and so forth)  
2. To assess the type, degree and configuration of the hearing loss 
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3. To explore the type of hearing symptom onset (e.g. sudden or gradual/progressive onset) 
4. To document case history data such as signs and symptoms of each participating participant and to identify any 
associations between obtained signs and symptoms and hearing loss 
 
Design of the Study 
 
As an extensive literature search yielded a paucity of both South African and internationally published data on this 
topic, the study was exploratory. The design utilized was prospective and qualitative in nature (Devore, 1999). The aim was 
to investigate the auditory status in a group of adults with AIDS prior to commencement of antiretroviral therapy; hence all 
measures were taken before commencement of ART. 
 
Participants 
 
A total sample of 150 participants comprised the study. The patients selected for this study were recruited from the 
Hospital’s Adult HIV/AIDS clinic. Patients who attend this clinic have already been diagnosed with HIV/AIDS and are seen 
there for general medical management as well as antiretroviral treatment and monitoring. At the time of the study all patients 
with CD4+ counts below 200 cells/mm3 were assessed and counselled for ART at this clinic - and the current study targeted 
this group before they enrolled in the treatment. 
 
Participant selection criteria 
 
Due to the exploratory nature of the current study; and given the fact that little, if any, published research has been 
conducted on this aspect of HIV/AIDS in South Africa, the researcher believed that it was crucial to have a sample that was 
as closely representative of the general AIDS population as possible; while closely recording medical history that could have 
had an influence on the results. This medical history was obtained from both case history interviews and from medical 
records. To this end, criteria stipulated in Table 1 were observed. 
 
Table 1: Summary of participant Inclusion Criteria and Recorded history 
Criterion Inclusion History recorded  
HIV/AIDS positive serology Yes √ 
History of ART  √ 
Age between 18 and 50 years Yes  
Alert and oriented Yes  
Noise exposure  √ 
Recent (less than 3 years) or current history of treatment for TB and 
radiotherapy  
 √ 
Positive clinical or serological evidence of syphilis  √ 
Middle ear pathology   √ 
Medical ear related history   √ 
Family history of hearing loss  √ 
 
Recruitment and Sampling Procedure 
 
A nonprobability convenience sampling technique was utilized in the study since the sample was restricted to a part 
of the population that was readily available (Devore, 1999; Schiavetti and Metz, 2002), and true random sampling would 
have been difficult to achieve due to time, cost, and equipment limitations. Participants were approached at the clinic and 
asked to volunteer to participate in the study following an explanation of what the study entailed. 
 
Research procedures and materials 
 
Participants underwent case history interviews and medical record reviews, otoscopy and tympanometry, as well as 
conventional pure tone audiometry testing. Data were collected from assessing participants’ dependant variables before 
administration of ART. Following infection control measures proposed by Kemp and Roeser (1998), all testing was 
conducted in a sound-proof booth.  
 Case History: 
A case history form that targeted the signs and symptoms of auditory manifestations was utilized in order to gather all the 
important case history information, audiological data and some medical variables that could have exerted an impact on the 
results of the study. 
 Otoscopy: 
The researcher evaluated the participants’ ears for the presence of impacted wax; otitis externa; possible otitis media; 
perforated tympanic membranes; collapsed ear canals; presence of any growths and any other ear disorders (Friedman and 
Arnold, 1993). These otoscopic abnormalities are reported to have a significant effect on DPOAE and therefore needed to be 
documented before testing commenced (Hall, 2000). 
 Tympanometry: 
Tympanometry (through the use of the Inter-Acoustic AZ26 audiotympanometer) was utilized to assess the status and 
integrity of middle ear functioning. Standard single frequency tympanometry using an 85dB SPL tone set at 226Hz was done.  
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 Pure tone audiometry: 
Conventional (250Hz-8000Hz) pure tone audiometry was performed on all participants through the use of the Inter-Acoustic 
AC 40 diagnostic audiometer. The criteria used to define normal hearing, was that of pure tone thresholds of 25dBHL or 
lower across all frequencies, with the absence of an air-bone gap (Martin and Clark, 2003). Where pure tone air conduction 
and tympanometry were abnormal at any test frequencies, bone conduction testing was conducted to determine the type of 
hearing loss. Participants presenting with abnormal findings were referred to an Ear, Nose and Throat Specialist for 
assessment and management, and were subsequently offered appropriate audiological rehabilitation. 
 
Validity and Reliability 
 
Test reliability was controlled and maintained at a high level by standardizing test administration, ensuring proper 
equipment calibration, and controlling patient variables. For all audiological assessments precautionary measures advocated 
by Bess and Humes (1990) and Hall (2000) were followed in terms of proper maintenance and calibration of the equipment; 
optimizing testing environment; correct earphone and bone vibrator placement, and proper probe placement for 
tympanometry. All testing was conducted in a soundproof booth or sound-treated room with equipment that was calibrated on 
an annual basis, with biologic calibration conducted before every test session. All participants were tested by the same 
researcher using the same test procedure. Furthermore, all patients were tested in the mornings to reduce the effect that 
fatigue can have on patients’ responses to behavioural audiometry testing. 
 
Data Analysis and Statistical Procedures 
 
Participants’ results were descriptively analysed and classified as either normal or abnormal. Normal hearing was 
taken as normal tympanometric results in the presence of normal otoscopic findings with pure tone responses at or better than 
25 dB HL, with hearing loss being thresholds greater than 25dB HL with air-bone gaps greater than 10dB (Bess and Humes, 
1990; Silman and Silverman, 1991). This stage of analysis aimed at determining the prevalence of hearing loss in the sample 
evaluated. For all participants presenting with abnormal auditory function, findings were further categorized into type of 
hearing loss; severity or degree of the loss; and type of onset of the hearing loss.  
The hearing losses were classified into the three well-documented types of hearing losses (conductive - CHL; mixed - MHL; 
and sensorineural - SNHL) (Bess and Humes, 1990; Jacobson and Northern, 1990). SNHL was not further differentiated into 
cochlear (sensory) versus retrocochlear (neural), and this is acknowledged as another limitation of the current study.  
The degree of hearing loss was determined using Silman and Silverman’s (1991) classification of Magnitude of Hearing 
Impairment. This classification system, in line with Bess and Humes (1990), Gilbert, Smith and Stayner (2003), and Katz 
(1994) proposes that impaired hearing function begins at an average hearing level of 25 dB HL, and is categorized as seen in 
Table 2. 
 
Table 2: System of classification of hearing loss in terms of degree of loss (Silman and Silverman, 1991) used in the current 
study 
Average Hearing Level dB Description 
< 26 dB Normal range 
26dB – 40 dB Mild hearing loss 
41dB – 55 dB Moderate hearing loss 
56dB – 70 dB Moderately severe hearing loss 
71dB – 90 dB Severe hearing loss 
>91 dB Profound hearing loss 
 
Furthermore, in classifying the degree of the hearing loss, the researcher looked at the configuration of the loss and added 
categories depicting this change in degree of loss at frequency ranges (i.e. mild-moderate; severe-profound).  
 
Configuration of hearing loss was established by describing the pure tone results as depicting flat, irregular, rising 
(low frequency), sloping (high frequency) configuration (Katz, 2002). Symmetry of hearing loss was also examined where 
the researcher established whether the hearing loss was unilateral or bilateral, and whether it was symmetrical or 
asymmetrical (Katz, 2002). The type of onset of hearing symptoms was also analysed where descriptors such as gradual, 
gradual/progressive, sudden, and sudden/progressive onset were used to define the manner in which the symptoms presented, 
based on patient reports. All significant case history factors and Ear, Nose and Throat Specialists’ reports were recorded and 
analyzed along with the audiological results in order to obtain a comprehensive assessment and to ensure that participants 
presenting with hearing loss deemed (based on Ear, Nose and Throat Specialists’ reports) to be opportunistic infection related 
were identified.  
 
Ethical Consideration 
 
Prior to commencement of the study, permission to conduct the research project was sought from the University of 
the Witwatersrand Human Research Ethics Committee (Medical) which gave unconditional ethical clearance in the form of 
protocol number M041131. The researcher ensured that permission to conduct the study was obtained from the Hospital 
management and from the Heads of the Audiology and HIV/AIDS clinics at the research site. Written informed consent to 
participate in the study was obtained from all participants before the study was conducted with an assurance that 
confidentiality of all records would be maintained. Furthermore, to ensure anonymity, the researcher ensured that no personal 
or identifying information was included in the research report and research coding numbers instead of identifying information 
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were used. The current study also reduced risks to the participants to a minimum by conforming to the ethical principles 
(South African Medical Research Council, 2003) and observing provisions of the Nuremberg Code of ethics (Newell and 
Burnard, 2006) during the study. Lastly, the hospital and participants were given the opportunity to request to see the 
research results if they were interested.  
 
 
RESULTS AND DISCUSSION 
Description of Participants  
 
As depicted in Table 3, the sample included 53 (35%) males and 97 (65%) females between the ages of 20 and 46 
years with a mean age of 33.9 years. The average CD4+ count was 124 cells/mm3 which was consistent with the CD4+ 
requirement that persons need to have before they can be enrolled in an ART programme in South Africa (i.e. CD4+ has to be 
below 200 cells/mm3).  
 
Table 3: Demographic and CD4 count data of participants (N = 150) 
FACTOR SUB-CATEGORY NO. 
Age (Years) 
 
Range 
Mean 
20-46yrs 
33.9yrs 
Gender Male 
Female 
53 (35%) 
97 (65%) 
Ethnic Group Black 
White 
Coloured 
Indian 
141 (94%) 
0 
9 (6%) 
0 
CD4+ Count (cells/mm3 ) 
 
Mean 
Standard deviation 
123.5133 
69.00294  
 
Close inspection of the demographic profile of the participants in the current study reveals similarities between the sample 
evaluated and the general South African population infected with HIV/AIDS with regard to age, gender and race (Dorrington 
et al., 2006). This therefore implies a strong similarity to the South African population infected with HIV/AIDS, suggesting 
that the current study was performed on a sample that was fairly representative of the South African situation, particularly 
persons attending public health clinics. Dorrington et al. (2006) assert that women continue to have the highest HIV 
prevalence rates in the country. Most recent antenatal clinic data show that the prevalence rates amongst women exceeds 
30% and that of men just over 25% (Dorrington et al., 2006). As in the rest of sub-Saharan Africa, HIV has been noted to 
disproportionately affect more women than men (Shisana and Simbayi, 2005). This gender bias in the prevalence rates of the 
disease was also evident in the sample recruited for the present study, with a much higher number of participants in the study 
being female. 
 
 
The prevalence rate of hearing loss  
 
 
Figure 1: The prevalence rate of hearing loss in the sample of patients with AIDS (N = 150) 
 
Of the total sample of 150 participants evaluated, 135 (90%) had normal hearing, and 15 (10%) presented with a clinical 
hearing loss (Figure 1). Over and above changes in audiological function, participants with clinical hearing loss in the current 
study also presented with associated symptoms of hearing loss in the form of tinnitus and dizziness (Figure 2). Ten (67%) of 
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the participants presented with associated tinnitus, 4 (27%) experienced dizziness, and 4 (27%) had simultaneous experience 
of dizziness and tinnitus. The significantly lower prevalence of dizziness in comparison to tinnitus is reassuring since this 
sign is believed to be more debilitating to the patient and can significantly affect the patients’ quality of life (Katz, 2002). 
 
Figure 2: The occurrence of tinnitus and dizziness in the group of participants with clinical hearing loss (n=15) 
 
These findings are consistent with previous reports on auditory manifestations of HIV/AIDS. The 10% that presented with 
hearing loss in the current sample is considered to be high since this sample only consisted of participants in the AIDS stage 
and excluded the earlier stages of the disease. This sample also did not include the effects of medications on hearing function 
since participants had not enrolled in ART at the time of data collection. This high occurrence of hearing loss in the sample 
assessed underscores the need for more research into this population to enhance generalizability of results so that vital 
decisions can be made regarding the anticipated burden of disease. Given the prevalence and disease burden of undetected 
hearing impairment and the availability of effective treatments, it is important for audiologists to engage early in the 
assessment and management of this population before quality of life is severely compromised.  
  
 
Assessment of the type, degree, configuration, and symmetry of the hearing loss 
Types of hearing loss 
 
Of the 15 participants with clinical hearing loss, 11 (73%) had sensorineural hearing loss (SNHL); 4 (27%) had 
conductive hearing loss (CHL); and none had mixed hearing loss (MHL) (Figure 3).  
 
 
Key:  CHL = Conductive hearing loss; MHL = Mixed hearing loss; SNHL = Sensorineural hearing loss 
Figure 3: Types of hearing loss in the sub-sample of participants with clinical hearing loss (n =15) 
 
In reviewing the literature, the current findings provide support for the reports that claim the hearing loss seen in HIV/AIDS 
to be of any type (Chandrasekhar et al. 2000; Friedmann and Noffsinger, 1998; Khoza and Ross, 2002; Timon and Walsh, 
1989). The limited occurrence of CHL was not a surprising finding particularly since this was consistent with previous 
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findings (Khoza and Ross, 2002), of less occurrence of CHL in the AIDS stage even though otitis media has been reported to 
be most common in this population (Friedmann and Noffsinger, 1993; Gold and Tami, 1998; Lalwani and Sooy, 1992). The 
higher occurrence of SNHL in AIDS may be attributed to the progressive decline in patients’ immunologic status which 
potentially places the patients at risk for being susceptible to the neurotrophic nature of the disease and to opportunistic 
infections, which have been found to cause hearing loss. Because of the permanent nature of SNHL when compared to CHL, 
findings from the current study highlight the need for increased awareness of this AIDS manifestation to ensure that 
rehabilitation in the form of diagnostic testing as well as amplification occurs. Moreover, counselling regarding 
communication enhancing strategies for both the patient and the family can be implemented early, thereby minimising the 
documented negative effects that a hearing impairment can have on an individual. 
 
Degree of hearing loss 
 
Following the classification of degree of hearing loss previously reported; it became evident that the hearing loss 
could occur in any degree of severity as depicted in Figure 4. However, the most prevalent degree of severity of hearing loss 
was the mild-moderate hearing loss followed by the severe degree of hearing impairment. Of the 15 participants, 9 (60%) 
presented with mild to moderate hearing loss while 3 (20%) presented with severe hearing loss.  
 
Key:  Mod = Moderate; Sev = Severe; Prof = Profound; L = left; R = right; Bi = bilateral 
Figure 4: Degree and symmetry of hearing loss in the sub-sample of participants with clinical hearing loss (n = 15) 
 
These results are consistent with those reported in the literature where severity of hearing loss has been described 
as ranging from mild to severe with little mention of profound hearing loss – as was found in the current study. Despite the 
absence of the profound degree of hearing impairment in this sample, the implications for the patients’ quality of life are still 
significant; and the role of the audiologist with regard to early and prompt effective services to this population is highlighted. 
Unaided severe hearing loss can have an influence not only on the patient’s everyday listening environment; but in this case, 
may also have an influence on the patient’s ability to follow treatment protocols; and subsequently adherence to ART.    
 
Configuration of hearing loss 
 
No typical pattern of configuration of hearing loss could be established before antiretroviral treatment was 
instituted. In the total sub-sample (n = 15) of patients with hearing loss, 5 (33%) participants presented with a sloping/high 
frequency hearing loss while the remaining 67% presented with flat and/or irregular audiograms with an equal chance of 
involvement of all frequencies. These results are consistent with findings documented by Khoza and Ross (2002) on patients 
who were also not taking ART, where they found that all frequencies were affected equally or to varying degrees, depending 
on the possible cause of the hearing loss, and the hearing loss was not necessarily confined to high frequencies as previously 
reported. Several authors have reported a tendency towards sloping/high frequency hearing loss, and this finding was not the 
general trend observed in the current study. Findings from the current study were thought to vary due to the fact that the 
participants were treatment naïve, and so ototoxic hearing loss often presenting as high frequency hearing loss was not the 
main presenting manifestation. 
 
Symmetry of hearing loss 
 
Of the total sub-sample of 15 participants with abnormal hearing, 7 (47%) had unilateral hearing impairment while 
8 (53%) presented with bilateral hearing loss (Figure 3 and Table 3). Although there appears to be a dearth of reported data in 
respect to symmetry of hearing loss in adults infected with HIV/AIDS, the current study demonstrated that the hearing loss 
can be unilateral or bilateral, and can also be bilaterally symmetrical or asymmetrical (Table 3). This finding, when combined 
with the degree of hearing loss most prevalent in this population, stresses the importance of prompt audiological assessment 
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and management of patients with AIDS. These findings highlight the crucial need for communication rehabilitation services 
by audiologists to minimise or eliminate the impact that the hearing impairment may have on the individual’s communicative 
skills. 
 
Type of onset of hearing symptoms 
 
Of the entire sample with hearing loss, all the participants (100%) presented with gradual/progressive hearing loss 
with no participant presenting with sudden onset of symptoms. These results are inconsistent with earlier reports by Khoza 
and Ross (2002) which revealed that sudden onset was mostly experienced by participants who presented with severe to 
profound SNHL, while gradual onset was mostly found in participants who presented with conductive and/or mixed hearing 
losses. In the current study, regardless of the type or degree of hearing loss, all participants presented with gradual onset of 
hearing loss. This type of onset of hearing loss probably explains the late patient presentation of symptoms to their physicians 
as patients may learn to compensate as the hearing loss gradually deteriorates. 
 
Case history information 
 
Table 4: Case history and medical information for participants with clinical hearing loss (n=15) 
Participant Age (yrs) Type of Hearing 
Loss 
Medical History Ear History 
Participant 44s 30 Bilateral severe 
conductive hearing 
loss  
Otitis media Perforated tympanic 
membrane; Chronic 
suppurative otitis media 
Participant 45s 41 L-mild-moderate 
sloping SNHL 
Unknown None 
Participant 53 24 R-mild moderate 
CHL 
Otitis media Otitis media with effusion 
Participant 54 32 Bilateral mild 
SNHL 
? otosyphilis None 
Participant 61 46 L-Mild moderately 
severe SNHL 
Unknown History of otalgia 
Participant 80 39 R-mild-moderate 
CHL 
Otitis media Perforated tympanic 
membrane; Chronic 
suppurative otitis media 
Participant 83 33 Bilateral moderate 
severe SNHL 
Otosyphilis None 
Participant 88 46 Bilateral moderate 
severe SNHL 
Meningitis None 
Participant 89 41 L-moderate severe 
SNHL 
Unknown Hearing loss 
Participant 97 29 Bilateral mild 
moderate sloping  
SNHL 
TB treatment and 
syphilis treatment 
None 
Participant 102 20 L-severe profound 
SNHL 
Syphilis & Viral 
meningitis 
Hearing loss 
Participant 104 39 Bilateral mild 
moderate SNHL 
Unknown None 
Participant 2c 29 Bilateral sloping 
mild moderate 
SNHL 
Herpes None 
Participant 44c 30 Bilateral severe 
CHL 
Otitis media Perforated tympanic 
membrane; Chronic 
suppurative otitis media 
Participant 45c 41 L- mild moderate 
sloping SNHL 
TB treatment and 
noise exposure 
None 
Key:  L = left; R = right 
 
Detailed analysis of the audiologic evaluation results together with the documented case history information where medical 
diagnoses had been confirmed by Ear, Nose and Throat Specialists (Tables 4 and 5) revealed the following: 
 Patients who presented with SNHL had documented medical histories of meningitis; infections (syphilis and 
otosyphilis); and histories of ototoxic medication used in the treatment of TB and other opportunistic infections. 
Four participants had unknown causes of hearing loss.  
 Patients who presented with CHL had a history of chronic suppurative otitis media, and otitis media with effusion. 
 
Possible causes of hearing loss found in the current study are consistent with literature reviewed. These findings were not 
surprising as these conditions are commonly seen in persons living with HIV/AIDS where immunological status has been 
severely compromised (Khoza and Ross, 2002; Larsen, 1998), and in up to 50% of HIV-infected people with hearing loss, no 
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cause can be identified (Lalwani and Sooy, 1992). The fact that some of these causes are treatable causes which means 
reversible hearing loss once again highlights the importance of ensuring that patients with AIDS get audiologically monitored 
so that auditory manifestations can be identified early and Ear, Nose and Throat specialist management can be instituted to 
prevent the symptoms from becoming permanent.    
 
 
Table 5: Summary of case history data and results for participants with clinical hearing loss (n=15) 
FACTOR SUB-CATEGORY NO. PERCENTAGE  
Gender Female 
Male 
8 
7 
53 
47 
Age 
 
CD4+ 
Average Age 
 
Average CD4+ 
33.9yrs (Range 20-46yrs) 
123.5 (Range 2-265 
cells/mm3)  
Not applicable 
Hearing Function Hearing loss 15 10 
Type of Hearing Loss Conductive Hearing Loss 
Sensorineural Hearing 
Loss 
Mixed Hearing Loss  
 4 
 
11 
 
0 
27 
 
73 
 
0 
Type of onset of Hearing 
Loss 
Sudden 
Gradual 
0 
15 
0 
100 
Symmetry of Hearing 
Loss 
Unilateral 
Bilateral 
7 
8 
47 
53 
Possible aetiology of 
Hearing Loss * 
Meningitis 
Oto/syphilis 
Otitis Media 
Herpes 
TB Treatment 
Unknown 
Noise exposure 
2 
4 
4 
1 
2 
4 
1 
13% 
27% 
27% 
7% 
13% 
27% 
7% 
Degree of Hearing Loss  
(n=15) 
Mild 
Mild-moderate 
Moderate 
Moderate-severe 
Severe 
Severe-profound 
Profound  
1 
8 
1 
1 
3 
1 
0 
7 
53 
7 
7 
20 
7 
0 
Tinnitus Present 
Absent 
10 
5 
67 
33 
Vertigo Present 
Absent 
4 
11 
27 
73 
Tinnitus & Vertigo Present 4 27 
*% Scores do not add up to 100% as some participants presented with more than one possible aetiological factor. 
 
Conclusions 
 
Limitations to the current study were present, and they included the fact that there was limited control over 
confounding variables such as previous exposure to ototoxic drugs. Furthermore, due to the sample size and the fact that the 
data were collected in one hospital in Gauteng, South Africa, the researcher’s ability to generalize the results from the sample 
studied to the total population of adults with AIDS in South Africa is limited. From the findings of the current study it is 
clear, however, that there is great heterogeneity in presentation of the auditory manifestations of AIDS. With the exception of 
Khoza and Ross (2002), studies reviewed were mostly from developed countries where the presentation as well as the 
treatment of HIV/ AIDS may be different to that in developing countries. Hence, more investigation is required in this 
population, which underpins the rationale for intensified efforts into audiological research into HIV/ AIDS.  
Audiological research into HIV/ AIDS may clearly demonstrate the potential role of the audiologist in both the 
assessment and treatment of patients AIDS. Most importantly, research conducted in specific contexts where the disease has 
varied effects as well as varied treatments may yield findings that are more relevant and evidence-based. Research conducted 
within the South African context; a context considered to be the epicentre of the African HIV pandemic; and a context that is 
acknowledged to present unique challenges of which political, social, economic, health, equipment, and personnel problems 
are deemed non-exhaustive; is crucial. Such research can directly inform the assessment and management protocols of this 
population, thereby impacting positively on their quality of life. These protocols can only be implemented if the audiological 
manifestations of AIDS and its treatments within a specific context have been clearly characterised.  
Characterisation of the burden of disease has significant implications for developing countries where financial 
constraints guide the prioritisation of resources. For example, if the correct prevalence of audiologic manifestations of AIDS 
could be established, appropriate budget planning could be employed, which would have a direct influence on resource 
management for this population. Furthermore, when budgets are allocated for comprehensive HIV/ AIDS management, 
audiological services could be included in the programmes. Recommendations may need to be made for audiological services 
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in terms of the provision of sensitive and objective equipment (such as measures of otoacoustic emissions [OAEs]) as well as 
the appointment of audiologists at HIV/AIDS clinics in state institutions. 
While there are some clear auditory manifestations that were found in the current study, there is still a small 
evidence base. Findings regarding the prevalence as well as nature of auditory dysfunction in adults with HIV/ AIDS need to 
be replicated in other communities and populations in Africa, especially since sub-Saharan Africa has such high HIV 
incidence. Because of the vast variance in contexts, the differences in the patient populations studied, the wide range of 
methodological approaches employed, and so on — findings from international studies cannot easily be generalised to the 
African context. Furthermore, certain issues such as time of ART initiation, use of complimentary or alternative medicine in 
the African context, and how these may impact auditory function have not received attention. Hence, more context-relevant, 
current and updated research which utilises standardised and sensitive research instruments for ease of comparability of the 
findings is clearly needed to address this situation. Such research should also include more controlled studies to establish 
definitive links between HIV/ AIDS and its drug treatments with auditory function. Research should also include continuous 
reviews of prevalence and incidence data, as the nature of the disease and its manifestations may be changing. These research 
efforts would greatly enhance the development of a more consolidated body of evidence that can then be used to contribute to 
policy-making and programme design and implementation, while at the same time improving the efficacy of clinical practice. 
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